I took our first list back in February, to see how we did. A lot happened, but some later than predicted. Biggest item not done yet is financing, which has held the share price down. My guess is most shares being sold are related to that still unfinished item. Getting close once we get the BLA submitted. NP gave a good explanation yesterday about it.

Also what every happened to TNBC ODD?

What do you think is the next big news item (that would move share price > 10%)?
My guess would be the BLA Part 2 submission,
Also Mono pivotal trial approval or reduction in CTCs for tnbc patient would be big.

We have
CDRH Face-to-Face Meeting Aug 28
Mono meeting September 20th
GvHD first patient injection: September
BLA part 2 September
BLA part 3 September